Evidence-informed prioritization of interventions for integrating hypertension management into cardiovascular-kidney-metabolic care in primary health care: HEARTS 2.0 Phase 3.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ordunez Pedro, Rosende Andres, Ratti Maria Florencia Grande, DiPette Donald J, Torres Ana Marcela, Londoño Esteban, Angell Sonia Y, de la Cerda Mariana L Rodriguez, Campbell Norm R C, Martínez Libardo Rodríguez, Brettler Jeffrey, Tortosa Fernando, Irazola Vilma, Jaffe Marc G, Izcovich Ariel, Chapman Niamh, de la Rosa Andelys, de Souza Ana Claudia, Aguilera Miguel Angel Diaz, Valencia Paula Diaz, Flood David, Jarquin Lourdes, Khan Taskeen, Mariani Javier, Moran Andrew E, Ojeda Carolina Neira, Ridley Emily, Rivera Marcela, Rodriguez Gonzalo, Romero Cesar A, Torroba Santiago, Gonzalez Yamile Valdes, Vensentini Natalia, Wellmann Irmgardt A, Zuniga Eric, Reveiz Ludovic, Whelton Paul K
Аннотация
METHODS: Building on previous phases of HEARTS 2.0, a multidisciplinary panel evaluated 45 candidate interventions in different areas. The selection process utilized structured evidence appraisal, Evidence-to-Decision frameworks, and a modified RAND/UCLA appropriateness method involving anonymized rating rounds.
RESULTS: A total of 38 interventions were prioritized for implementation. Although hypertension management remains the primary entry point, the resulting framework integrates early detection of diabetes and chronic kidney disease, lifestyle interventions, risk-based combination pharmacotherapy, task-sharing, and longitudinal follow-up.
CONCLUSIONS: By translating dispersed guideline recommendations into implementable interventions, Phase 3 of HEARTS 2.0 provides an evidence-informed basis for advancing integrated CKM care at scale in PHC and guiding the forthcoming update of the HEARTS Clinical Pathway. The resulting framework offers a flexible, scalable approach for countries confronting similar epidemiological and health system challenges.